InvestorsHub Logo
Followers 13
Posts 1546
Boards Moderated 0
Alias Born 06/14/2018

Re: None

Thursday, 01/10/2019 6:40:00 PM

Thursday, January 10, 2019 6:40:00 PM

Post# of 34625
I'm looking at the current price of MRKR and wondering WHY, with all the Many Billions that have been thrown into the CAR T Cell Therapy space, why these people don't catch onto what MRKR is doing.
WHY is all the money going into CAR T cell and not into MultiTAA T cell?
WHAT are the major differences between the two different T cell therapies?

CAR T is genetically engineered.
MultiTAA T is not (safer?).

Time to patient:
CAR T - 4 to 6 weeks?
MultiTAA T - 1 week?

Cost to patient:
CAR T - 10 times as much as MultiTAA T.
MultiTAA T - 1/10th the cost.

Horrible side effects:
CAR T - cytokine release syndrome (which has killed patients).
MultiTAA T - NO cytokine release syndrome.

Great side effects:
CAR T - ?
MultiTAA T -significant epitope spreading / additional tumor-associated antigens.

I don't know, I must be missing something.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News